Life Sciences Academy | EMA and MHRA initiatives in AI and Healthtech

AI has moved from pilot projects into everyday clinical and regulatory practice faster than most businesses anticipated. Healthcare regulators are adapting – most notably the EMA, which has been steadily expanding its remit beyond medicines into broader health technology governance. This webinar looks at that shift alongside the parallel reset underway in the UK, where the MHRA is overhauling its approach to AI regulation in healthcare. Our EU and UK speakers will offer a practical, up-to-date view of what these developments mean for life sciences and healthtech businesses operating across both markets.

Outline

• EMA’s new initiatives on AI and Healthtech, and implications for medicines and other health technologies
• UK developments: the MHRA National Commission into the Regulation of AI in Healthcare, legislative reform and government initiatives

AI liability and risk allocation in life sciences and healthcare: UK and EU perspectives